← Evidence map

ArticleBlood2026

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Nahia Gómez-Echarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42247308